APIS India Limited has announced a rescheduling of its board meeting, now set for February 13, 2026, to review and approve its quarterly financial performance. The meeting was originally scheduled for February 14, 2026, but has been moved due to unavoidable circumstances.

Rescheduled Board Meeting Details

The Board of Directors will now convene on Friday, February 13, 2026, instead of the previously announced Saturday, February 14, 2026. The meeting will be held at the company's registered office located at 18/32, East Patel Nagar, New Delhi-110008, in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Results Scope

The board will consider, approve, and take on record the unaudited financial results for both standalone and consolidated operations. These results will cover the quarter and nine months ended December 31, 2025, providing comprehensive insights into the company's financial performance during this period.

Trading Window Restrictions Remain Unchanged

Despite the date change, the trading window restrictions remain in effect as previously announced. The trading window closure that began on Thursday, January 1, 2026, will continue until 48 hours after the declaration of the financial results, in accordance with the company's Code of Conduct for Prevention of Insider Trading.

During this closure period, all designated persons, including insiders and their immediate relatives, are strictly prohibited from entering into any transactions involving the company's securities.

Corporate Communication

The rescheduling announcement was communicated through letter number AIL/CS/2025-26/454 dated February 06, 2026, signed by Amit Anand, Managing Director (DIN: 00951321). This follows the earlier intimation vide letter no. AIL/CS/2025-26/453 dated February 04, 2026, regarding the original meeting schedule. The company has made this updated information available on its official website at www.apisindia.com , ensuring transparent communication with stakeholders and regulatory authorities.

Apis has successfully completed a significant corporate action, allotting bonus shares and substantially increasing its paid-up capital.

Bonus Share Allotment

The company has allotted bonus shares in the ratio of 24:1, as follows:

• 13,22,41,824 new fully paid-up equity shares
• Each share has a face value of Rs. 10
• Allotted to eligible shareholders as of the record date December 05, 2025

Impact on Share Structure and Capital

The bonus issue has had a substantial impact on the company's share structure and paid-up capital:

This represents an increase of approximately 2,500% in the paid-up equity share capital.

Rights of New Shares

The newly issued bonus shares carry the same rights as the existing equity shares, including:

• Voting rights
• Dividend entitlements

Previous Announcements

Prior to this allotment, the company had announced:

• A bonus share issue recommendation by the Board of Directors
• An increase in authorized share capital from Rs. 13.30 crore to Rs. 140.00 crore (subject to shareholder approval)

Financial Implications

The company had previously stated that it had sufficient free reserves and retained earnings (Rs. 134.04 crore) to implement the bonus issue, which required Rs. 132.24 crore.

This bonus share allotment by Apis India Limited represents the successful execution of a significant corporate action aimed at rewarding its shareholders. The substantial bonus ratio of 24:1 has significantly increased the number of outstanding shares, which may potentially enhance liquidity in the stock. However, shareholders should note that while their number of shares has increased, the overall value of their holding and the company's market capitalization typically remain unchanged immediately after a bonus issue.

Investors and shareholders are advised to consider this development in the context of their individual investment strategies and goals.